Genetic Signatures Limited (GSS.AX)

AUD 0.63

(-8.03%)

Market Cap (In AUD)

143.09 Million

Revenue (In AUD)

9.76 Million

Net Income (In AUD)

-17.86 Million

Avg. Volume

129.35 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.38-0.85
PE
-
EPS
-
Beta Value
0.054
ISIN
AU000000GSS4
CUSIP
Q4330L124
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Dr. Neil Gunn
Employee Count
-
Website
https://www.geneticsignatures.com
Ipo Date
2015-03-30
Details
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.